Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Human Health Holdings Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 5/6

Human Health Holdings şirketinin toplam hissedar öz sermayesi HK$766.7M ve toplam borcu HK$31.5M olup, bu da borç-öz sermaye oranını 4.1% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla HK$1.1B ve HK$289.7M dir. Human Health Holdings 'in FAVÖK'ü HK$19.7M faiz karşılama oranı -2.2 dur. Şirketin HK$489.6M tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

4.1%

Borç/özkaynak oranı

HK$31.54m

Borç

Faiz karşılama oranı	-2.2x
Nakit	HK$489.58m
Eşitlik	HK$766.67m
Toplam yükümlülükler	HK$289.71m
Toplam varlıklar	HK$1.06b

Son finansal sağlık güncellemeleri

Recent updates

Market Participants Recognise Human Health Holdings Limited's (HKG:1419) Revenues

Sep 13

Human Health Holdings Limited's (HKG:1419) Share Price Is Matching Sentiment Around Its Earnings

Jan 23

Human Health Holdings (HKG:1419) Seems To Use Debt Quite Sensibly

Mar 21

Shareholders May Be More Conservative With Human Health Holdings Limited's (HKG:1419) CEO Compensation For Now

Nov 26

Is Human Health Holdings (HKG:1419) Using Too Much Debt?

May 31

Estimating The Fair Value Of Human Health Holdings Limited (HKG:1419)

Feb 15

Is Human Health Holdings (HKG:1419) Weighed On By Its Debt Load?

Dec 25

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 1419 'nin kısa vadeli varlıkları ( HK$613.6M ) kısa vadeli yükümlülüklerini ( HK$215.8M ) aşıyor.

Uzun Vadeli Yükümlülükler: 1419 şirketinin kısa vadeli varlıkları ( HK$613.6M ) uzun vadeli yükümlülüklerini ( HK$73.9M ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 1419 şirketinin toplam borcundan daha fazla nakiti var.

Borcun Azaltılması: 1419 şirketinin borç/öz sermaye oranı son 5 yılda 3% seviyesinden 4.1% seviyesine yükseldi.

Borç Kapsamı: 1419 'nin borcu işletme nakit akışı ( 545.5% ) tarafından iyi bir şekilde karşılanmaktadır.

Faiz Kapsamı: 1419 ödediğinden daha fazla faiz kazandırıyor, dolayısıyla faiz ödemelerinin karşılanması bir sorun teşkil etmiyor.

Human Health Holdings Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 5/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Human Health Holdings (HKG:1419) Seems To Use Debt Quite Sensibly

Is Human Health Holdings (HKG:1419) Using Too Much Debt?

Is Human Health Holdings (HKG:1419) Weighed On By Its Debt Load?

Recent updates

Human Health Holdings Limited Announces Board and Committee Changes

Human Health Holdings Limited, Annual General Meeting, Dec 02, 2024

Market Participants Recognise Human Health Holdings Limited's (HKG:1419) Revenues

Human Health Holdings Limited to Report Q4, 2024 Results on Sep 25, 2024

Human Health Holdings Limited Provides Earnings Guidance for the Year Ended 30 June 2024

First half 2024 earnings released: EPS: HK$0.053 (vs HK$0.71 in 1H 2023)

Human Health Holdings Limited to Report First Half, 2024 Results on Feb 27, 2024

Human Health Holdings Limited's (HKG:1419) Share Price Is Matching Sentiment Around Its Earnings

Investor sentiment improves as stock rises 16%

Investor sentiment deteriorates as stock falls 16%

Upcoming dividend of HK$0.16 per share at 12% yield

Human Health Holdings Limited, Annual General Meeting, Dec 07, 2023

New minor risk - Profit margin trend

Human Health Holdings Limited Proposes Final Dividend for the Year Ended June 30, 2023, Payable on 29 December 2023

Human Health Holdings Limited to Report Fiscal Year 2023 Results on Sep 26, 2023

First half 2023 earnings released: EPS: HK$0.71 (vs HK$0.24 in 1H 2022)

First half 2023 earnings released: EPS: HK$0.71 (vs HK$0.24 in 1H 2022)

Human Health Holdings Limited to Report First Half, 2023 Results on Feb 24, 2023

Investor sentiment improved over the past week

Upcoming dividend of HK$0.30 per share

Less than half of directors are independent

Full year 2022 earnings released: EPS: HK$0.99 (vs HK$0.38 in FY 2021)

Full year 2022 earnings released: EPS: HK$0.99 (vs HK$0.38 in FY 2021)

Human Health Holdings Limited, Annual General Meeting, Dec 02, 2022

Investor sentiment improved over the past week

Human Health Holdings Limited to Report Fiscal Year 2022 Results on Sep 29, 2022

Human Health Holdings Limited Provides Earnings Guidance for the Year Ended 30 June 2022

Less than half of directors are independent

Investor sentiment improved over the past week

Human Health Holdings (HKG:1419) Seems To Use Debt Quite Sensibly

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment improved over the past week

Human Health Holdings Limited to Report First Half, 2022 Results on Feb 25, 2022

Human Health Holdings Limited Provides Unaudited Financial Guidance for the Six Months Ended December 31, 2021

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Upcoming dividend of HK$0.12 per share

Shareholders May Be More Conservative With Human Health Holdings Limited's (HKG:1419) CEO Compensation For Now

Full year 2021 earnings released: EPS HK$0.38 (vs HK$0.11 loss in FY 2020)

Full year 2021 earnings released: EPS HK$0.38 (vs HK$0.11 loss in FY 2020)

Is Human Health Holdings (HKG:1419) Using Too Much Debt?

First half 2021 earnings released: EPS HK$0.045 (vs HK$0.008 in 1H 2020)

Estimating The Fair Value Of Human Health Holdings Limited (HKG:1419)

Human Health Holdings Limited to Report First Half, 2021 Results on Feb 24, 2021

New 90-day high: HK$0.68

Is Human Health Holdings (HKG:1419) Weighed On By Its Debt Load?

New 90-day low: HK$0.55

New 90-day low: HK$0.58

New 90-day low: HK$0.60

Human Health Holdings Limited Resolves Not to Declare Any Final Dividend for Financial Year 2020

Full year earnings released - HK$0.11 loss per share

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Sağlıklı şirketleri keşfedin